Position in GELS
as of Mar 31, 2026
· filed Apr 27, 2026
Position Value
$11,017
New position
Shares Held
16,668
first reported quarter
Ownership
0.156%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#2
of 5 holders
Holding Since
Mar 2026
1 quarter on record
Voting authority
Sole 0%
Shared 0%
None 100%
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026Private Advisor Group, LLC holds $12,585,036 across 16 Drug Manufacturers - Specialty & Generic names. GELS ranks #15 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ELAN |
Elanco Animal Health Inc
|
185,024 | $4,427,624 | |
| 2 | HLN |
Haleon plc
|
219,187 | $2,194,061 | |
| 3 | ZTS |
Zoetis Inc.
|
15,150 | $1,790,881 | |
| 4 | HIMS |
Hims & Hers Health, Inc.
|
42,625 | $884,895 | |
| 5 | TEVA |
Teva Pharmaceutical Industries Ltd
|
21,888 | $659,266 | |
| 6 | VTRS |
Viatris Inc
|
41,557 | $561,435 | |
| 7 | UTHR |
UNITED THERAPEUTICS Corp
|
890 | $527,752 | |
| 8 | TAK |
Takeda Pharmaceutical Co Ltd
|
26,488 | $490,557 |
All Filings in GELS
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $11,017 | 16,668 | Shares | Sole | 2026-04-27 | |
| No filing history on record for this holder in this stock. | ||||||